Insider Selling: Addus HomeCare (NASDAQ:ADUS) EVP Sells 3,499 Shares of Company Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Cliff Donald Blessing sold 3,499 shares of the business’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $123.91, for a total transaction of $433,561.09. Following the completion of the sale, the executive vice president directly owned 6,684 shares in the company, valued at approximately $828,214.44. This represents a 34.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Cliff Donald Blessing also recently made the following trade(s):

• On Friday, November 6th, Cliff Donald Blessing sold 2,000 shares of Addus HomeCare stock. The stock was sold at an average price of $124.18, for a total transaction of $248,360.00.

Addus HomeCare Stock Down 1.4%

Addus HomeCare stock traded down $1.77 during mid-day trading on Thursday, reaching $123.72. The company’s stock had a trading volume of 135,729 shares, compared to its average volume of 237,235. The company has a market capitalization of $2.30 billion, a price-to-earnings ratio of 20.62, a price-to-earnings-growth ratio of 1.66 and a beta of 0.75. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $131.59. The business’s 50 day simple moving average is $118.19 and its 200 day simple moving average is $107.10. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.64 and a current ratio of 1.64.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The firm had revenue of $387.74 million for the quarter, compared to analyst estimates of $388.72 million. During the same period in the previous year, the business earned $1.56 EPS. The company’s revenue was up 7.0% compared to the same quarter last year. As a group, research analysts anticipate that Addus HomeCare Corporation will post 6.41 earnings per share for the current year.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently bought and sold shares of the company. NFJ Investment Group LLC bought a new position in Addus HomeCare during the second quarter worth about $29,000. Heritage Family Offices LLP bought a new stake in Addus HomeCare in the third quarter valued at approximately $43,000. Parallel Advisors LLC raised its stake in Addus HomeCare by 66.3% in the first quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock valued at $38,000 after buying an additional 161 shares during the period. Hantz Financial Services Inc. raised its stake in Addus HomeCare by 21.3% in the third quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock valued at $69,000 after buying an additional 109 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in shares of Addus HomeCare by 16.9% in the third quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock valued at $85,000 after buying an additional 111 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Zacks Research upgraded Addus HomeCare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. Citigroup downgraded Addus HomeCare from a “market outperform” rating to a “neutral” rating in a report on Monday, September 14th. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 7th. Bank of America cut shares of Addus HomeCare from a “buy” rating to a “neutral” rating and decreased their target price for the company from $140.00 to $125.00 in a research note on Monday, September 14th. Finally, Royal Bank Of Canada boosted their target price on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $134.70.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.